NDUFA13 anticorps

N° du produit ABIN537353

Détail du produit anti-NDUFA13 anticorps

Antigène: NDUFA13 (NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, 13 (NDUFA13))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NDUFA13 est non-conjugé

Application: Western Blotting (WB)

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of NDUFA13.

Réactivité croisée: Humain

Immunogène: A mixture of synthetic peptides corresponding to human NDUFA13.

Information d'application

Indications d'application: The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.05 % BSA, 0.05 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-NDUFA13 (ABIN537353)

Knuefermann, Schwederski, Velten, Krings, Ehrentraut, Rüdiger, Boehm, Fink, Dreiner, Grohé, Hoeft, Baumgarten, Koch, Zacharowski, Meyer: "Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9." dans: Cardiovascular research, Vol. 78, Issue 1, pp. 26-35, (2008) (PubMed).

Wang, Barke, Charboneau, Schwendener, Roy: "Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 180, Issue 5, pp. 3594-600, (2008) (PubMed).

Ilvesaro, Merrell, Swain, Davidson, Zayzafoon, Harris, Selander: "Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro." dans: The Prostate, Vol. 67, Issue 7, pp. 774-81, (2007) (PubMed).

Tran, Koch, Berkels, Boehm, Zacharowski, Baumgarten, Knuefermann, Schott, Kanczkowski, Bornstein, Lightman, Zacharowski: "Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation." dans: The Journal of clinical endocrinology and metabolism, Vol. 92, Issue 7, pp. 2773-83, (2007) (PubMed).

Patole, Pawar, Lech, Zecher, Schmidt, Segerer, Ellwart, Henger, Kretzler, Anders: "Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice." dans: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 21, Issue 11, pp. 3062-73, (2006) (PubMed).

Détails sur NDUFA13

Antigène: NDUFA13 (NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, 13 (NDUFA13))

Autre désignation: NDUFA13 (NDUFA13 Produits)

Synonymes: anticorps GRIM-19, anticorps Ndufa13, anticorps B16.6, anticorps CDA016, anticorps GRIM19, anticorps 2700054G14Rik, anticorps AU022060, anticorps CGI-39, anticorps Grim19, anticorps RGD1565358, anticorps YJEFN3, anticorps NADH:ubiquinone oxidoreductase subunit A13, anticorps NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13, anticorps cell death-regulatory protein GRIM19, anticorps GRIM-19 protein, anticorps NADH:ubiquinone oxidoreductase subunit A13 L homeolog, anticorps ndufa13, anticorps LOC655421, anticorps Ndufa13, anticorps CpipJ_CPIJ000908, anticorps Bm1_18845, anticorps ndufa13.L, anticorps NDUFA13

ID gène: 51079

Pathways: Protein targeting to Nucleus, Negative Regulation of intrinsic apoptotic Signaling